Become An Entradan

Learn more about working at Entrada and how you can join our team

Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics

Headquartered in Boston, Entrada is a private company that completed its Series A in December 2018. Entrada's family of investors includes 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund, and Agent Capital.

At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platform to yield treatments for patients in need.

What we all have in common is our devotion to patients and our passion for science.

Our Values

  • Humanity

    We genuinely care about patients and about one another

  • Tenacity

    We’re relentless and persistent in the pursuit of developing therapies for patients

  • Creativity

    We’re creative problem solvers

  • Collaboration

    We’re more than the sum of our parts

  • Curiosity

    We’ve got a growth mindset

Join our team if you share our values, our devotion to patients and our passion for science

Meet Our Entradans

Kimberli Kamer
Scientist, Biology
Leo Qian
Co-founder & Head, Discovery Research
Nick Long
Scientist, Biologics R&D
Murali Mallem
Head, CMC
Luis Sandoval
Research Associate, Fermentation
Catherine O'Brien
Head, Clinical Operations
Patrick Dougherty
Scientist, Chemistry
Cecilia Sun
Head, Business Development & Operations

Current Openings

February 12, 2021

Director, Oligonucleotide Chemistry

Boston, MA

Learn more
February 11, 2021
February 10, 2021
February 10, 2021
February 08, 2021

Executive Assistant To CEO


Learn more
February 05, 2021
January 18, 2021
January 15, 2021
January 07, 2021

Principal Scientist, Bioinformatics

boston, MA

Learn more
December 18, 2020
August 31, 2020


Boston, MA

Learn more
April 22, 2020